HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
Dr. Castruccio Castracani is responsible for the management of research projects, which may include multiple moderate to large scale clinical trials or studies. He orients and trains staff handling research administration activities associated with conducting complex studies. Identifies adequate coverage for study staff needs across multiple projects, which vary in administrative complexity.
Dr. Castruccio Castracani holds the position of Clinical Research Study Manager at the Rivella Lab. After graduating from Pharmacy School in 2016 and attaining a Ph.D. in Neurosciences from the University of Catania in 2019, he became a member of the Rivella Lab in March 2020.
Initially joining as a Postdoctoral Fellow and progressing to the role of Research Associate Scientist I, Dr. Castruccio Castracani has been primarily engaged in researching gene therapy strategies for Congenital Sideroblastic Anemias (CSAs). These hereditary disorders, impacting mitochondrial iron metabolism, are scrutinized through a combination of in vivo and in vitro experiments, with a particular focus on X-linked sideroblastic anemia (XLSA) and its underlying mutations in the ALAS2 gene, disrupting normal heme biosynthesis.
He is also a past trainee of the Advanced Career Exploration (ACE) fellowship, organized by the Office of Academic Training and Outreach Programs (ATOP): from March to October 2023, he conducted a study on the burden of grants submission in the Office of Pre-Award Administration. In October 2023, Dr. Castruccio Castracani assumed the position of Clinical Research Study Manager. In this capacity, he operates independently, managing research projects encompassing moderate to large-scale clinical trials or studies.